FORMULATION AND EVALUATION OF ANTI-DIABETIC SUSTAINED RELEASE MATRIX TABLETS USING PROCESSED ALOE VERA MUCILAGE AS RELEASE MODIFIER Authors: Piyush Chandra , R.P. SINGH, MANOJ S. CHARDE
ABSTRACT
The main objective of the current study was to make and test continuous Repaglinide (RPGN)
matrix pills using aloe vera mucilage treated as a release modifier. A long-acting tablet should
release the required amount of medication with pre-determined kinetics in order to maintain the
effective plasma concentration that can be performed by making the drug release in a
predetermined and repetitive manner. These matrix tablets are compressed using a direct
compression method. The structure of the different tablets was prepared using a different
material: polymer ratio i.e., 1: 1, 1: 2, 1: 3, 1: 4, and 1: 5. Dry powder mucilage extracted from
Aloe vera leaves was tested with a resting angle, LBD, TBD, Carr index, and Hausner scale.
Prepared pills were tested according to pharmacopoeial standards. It was observed in kinetic
research that all formulations follow the kinetics of the first order and in particular the drug
release in its dosage form. The current work clearly demonstrates the possible use of ground aloe
vera (PAG) to correct drug release using different dosages. We can conclude that the modified matrix tablets that use PAG as mucilage can be used as a release mechanism in the formation of
continuous matrix tablets.
Keywords: Sustained release matrix tablets, natural polymers, repaglinide, synthetic
polymers, PAG
Publication date: 25/01/2022 https://ijbpas.com/pdf/2022/January/MS_IJBPAS_2022_JAN_SPCL_2_2057.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.1.2057